Literature DB >> 1572773

Evaluation of chemotherapy before limb-sparing surgery for osteosarcoma.

T Ishida1, M Takami.   

Abstract

Preoperative chemotherapy before limb-sparing surgery for osteosarcoma is used to reduce the size of the tumour, facilitate removal and prevent distant metastases. Fifteen patients with osteosarcoma were treated with six different protocols. Assessment of the clinical and radiological size of the lesion, of the histology of the resected specimen and of serum alkaline phosphatase levels were done. Greatest control of the tumour was obtained with the intravenous use of cisplatin, three times at intervals of three weeks before surgery, compared to the use of adriamycin or methotrexate in other protocols. Prompt surgery after preoperative chemotherapy and postoperative chemotherapy are advised.

Entities:  

Mesh:

Year:  1992        PMID: 1572773     DOI: 10.1007/bf00182987

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  5 in total

1.  Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms.

Authors:  G Rosen
Journal:  Recent Results Cancer Res       Date:  1986

2.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Authors:  K Winkler; G Beron; G Delling; U Heise; H Kabisch; C Purfürst; J Berger; J Ritter; H Jürgens; V Gerein
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

3.  Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.

Authors:  G Bacci; P Picci; P Ruggieri; M Mercuri; M Avella; R Capanna; A Brach Del Prever; A Mancini; F Gherlinzoni; G Padovani
Journal:  Cancer       Date:  1990-06-01       Impact factor: 6.860

4.  Comparison of intra-arterial cis-diamminedichloroplatinum II with high-dose methotrexate and citrovorum factor rescue in the treatment of primary osteosarcoma.

Authors:  N Jaffe; R Robertson; A Ayala; S Wallace; V Chuang; T Anzai; A Cangir; Y M Wang; T Chen
Journal:  J Clin Oncol       Date:  1985-08       Impact factor: 44.544

5.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

  5 in total
  1 in total

1.  Fertility following treatment of high-grade malignant bone and soft tissue tumors in young adults.

Authors:  Manabu Hoshi; Masatsugu Takami; Makoto Ieguchi; Masanari Aono; Jun Takada; Naoto Oebisu; Tadashi Iwai; Hiroaki Nakamura
Journal:  Mol Clin Oncol       Date:  2014-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.